Yamicc Live | Rotterdam 2025 During the 1st edition of Yamicc Live, we proudly presented our integral work for the first time. Exciting to mobilize leaders from various fields and collaborate on a shared goal whilst generating short- and long term value. A memorable moment it was! Few highlights; 🎤 A live brain surgery, streamed directly from the operating room and moderated by Prof Dr Clemens Dirven. Very impressive. 🎤 Dr Marjolein Geurts and Dr Martine Lamfers shared their (future) perspectives on personalized treatments and care, fueled by learnings and insight from the lab, research and the patient. From standard to personalized. 🎤 Roald Kruit spoke about Yamicc’s core principles and revealed something we have been building behind the scenes: a live demonstration of the Yamicc Trial Execution Platform. More to come! 🎤 Carli Wischhoff opened and closed the day, highlighting how joined forces and innovation can change lives. We would like to thank every one of you: attendees, partners, speakers and volunteers for making this launching event special. Together stronger in curing cancer – Are you in? We actually have quite a few things cooking: more coming soon! #YamiccLive #TrialExecutionPlatform #PersonalizedTreatments #Collabortion #AITechnology #RareCancer #HealthInnovation
kaiko.ai and Cori Clinical thanks for your help realizing the demo of our platform.
Big thanks to Carola Remers Annette Aué Jack Pieters Ashley Klapwijk Joy Iheoma van Geerestein & Lotte Dons - your help and support during the event made all the difference!
It’s been a great privilege and inspirational experience to attend the launch of Yamicc on behalf of Zorginstituut Nederland. Good luck to all involved with the next steps and with your admirable endeavor 👏🏼
Erik Heddema Charlotte Verkeyn Sascha Oosterbaan Buro Narratif Koalitix thanks for all your work!
Vet hoor!
Wow!!!
Wow great to see the vibe going on there. Amazing stuff!
Geweldig Roald!
Belangrijk initiatief! De ontwikkeling van een infrastructuur die innovatieve en gepersonaliseerde behandelingen sneller bij de juiste patiënt brengt, is van groot belang – zeker voor mensen met een zeldzame vorm van kanker. Bij 1 op 5 zetten we ons in om de toegang tot passende zorg voor zeldzame kankerpatiënten te verbeteren. Samenwerking tussen onderzoeksplatforms, klinieken en patiëntenorganisaties is daarbij essentieel. We volgen dit met grote interesse! #zeldamekanker #personalizedmedicine #clinicaltrials #samenwerkenvoorimpact #1op5